Axios on MSN

FDA smooths reviews of rare disease treatments

The Food and Drug Administration on Monday laid out a new pathway aimed at spurring novel individualized treatments targeting ...

FDA removes warning of crank autism cures–RFK Jr. nominates promoters

FDA takes down page warning of crank autism cures as RFK Jr. nominates people have promoted them - Robert F KennedyJr says ...

FDA proposes new system for approving customized drugs and therapies for rare diseases

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to ...

FDA proposes new treatment approval pathway for ultrarare diseases

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments ...
WSKG

The FDA creates a quicker path for gene therapies

The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would ...

FDA cracks down on weight-loss drug alternatives as thousands sickened in Maryland

Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened ...

FDA moves to facilitate personalized therapies for rare diseases

The Trump administration announced a new FDA approval pathway for individualized gene editing for rare diseases.

FDA will drop two-study requirement for new drug approvals, aiming to speed access

WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to ...
Texas Public Radio

FDA authorizes new drugs to treat New World screwworm in dogs and cats

The U.S. Food and Drug Administration issued two Emergency Use Authorizations for treating New World screwworm infestations ...

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics ...

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it ...